Literature DB >> 36125693

Dyslipidemia induced by lipid diet in late gestation donor impact on growth kinetics and in vitro potential differentiation of umbilical cord Wharton's Jelly mesenchymal stem cells in goats.

Alessandra Façanha Bezerra1, Juliana Paula Martins Alves1, César Carneiro Linhares Fernandes1, Camila Muniz Cavalcanti1, Maria Raquel Lopes Silva1, Alfredo José Herrera Conde1, Gildas Mbemya Tetaping1, Anna Clara Accioly Ferreira1, Luciana Magalhães Melo2, Ana Paula Ribeiro Rodrigues1, Davide Rondina3.   

Abstract

Mesenchymal stem cells (MSC) from the umbilical cord (UC) have several attractive properties for clinical use. This study aimed to verify the impact of a lipid-rich diet during late gestation of donor goats on the growth and differentiation of MSCs from UC. From the 100th day of pregnancy to delivery, 22 goats were grouped based on their diet into the donor-lipid (DLD; n = 11) and donor-baseline (DBD; n = 11) diet groups. Diets were isonitrogenous and isoenergetic, differing in fat content (2.8% vs. 6.3% on a dry matter basis). Wharton's jelly (WJ) fragments were cultured. After primary culture, samples of WJ-MSCs were characterized by the expression of CD90, CD73, CD34, CD45, CD105, and Fas genes, mitochondrial activity using MitoTracker (MT) fluorescence probe, and growth kinetics. Population doubling time (PDT) was also determined. WJ-MSCs were differentiated into chondrocytes, adipocytes and osteocytes, and the mineralized area and adipocytes were determined. The lipid diet significantly increased triglyceride and cholesterol levels during pregnancy. The DLD group showed sub-expression of the CD90 gene, a high MT intensity, and a low proliferation rate at the end of the subculture. The mean PDT was 83.9 ± 1.3 h. Mineralized area and lipid droplet stain intensity from osteogenic and adipogenic differentiations, respectively, were greater in DLD. We conclude that in donor goats, dietary dyslipidemia during late pregnancy affects the ability of UC-derived MSCs to express their developmental potential in vitro, thus limiting their possible use for therapeutic purposes.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Donor diet; Dyslipidemia; Goat; Lipid; Mesenchymal stem cell

Year:  2022        PMID: 36125693     DOI: 10.1007/s11259-022-09995-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.816


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 3.  Mitochondrial activity in the regulation of stem cell self-renewal and differentiation.

Authors:  Mireille Khacho; Ruth S Slack
Journal:  Curr Opin Cell Biol       Date:  2017-11-22       Impact factor: 8.382

4.  Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice.

Authors:  Sandra Bermeo; Ahmed Al Saedi; Christopher Vidal; Mamdouh Khalil; Manhui Pang; Bruce R Troen; Damian Myers; Gustavo Duque
Journal:  Bone       Date:  2019-02-16       Impact factor: 4.398

5.  Impact of donor nutritional balance on the growth and development of mesenchymal stem cells from caprine umbilical cord Wharton´s jelly.

Authors:  Juliana Paula Martins Alves; Rafael Rossetto; César Carneiro Linhares Fernandes; Assis Rubens Montenegro; Iolly Tábata Oliveira Marques; Camila Muniz Cavalcanti; Alessandra Façanha Bezerra; Ana Paula Ribeiro Rodrigues; Marcelo Bertolini; Davide Rondina
Journal:  Vet Res Commun       Date:  2021-10-09       Impact factor: 2.459

6.  The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.

Authors:  A Casado-Díaz; R Santiago-Mora; G Dorado; J M Quesada-Gómez
Journal:  Osteoporos Int       Date:  2012-10-27       Impact factor: 4.507

Review 7.  Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells.

Authors:  Huangcan Li; Zhuoying Feng; Ming-Liang He
Journal:  Theranostics       Date:  2020-05-30       Impact factor: 11.556

8.  Cellular hallmarks of aging emerge in the ovary prior to primordial follicle depletion.

Authors:  Victor A Ansere; Samim Ali-Mondal; Roshini Sathiaseelan; Driele N Garcia; José V V Isola; Jéssica D Henseb; Tatiana D Saccon; Sarah R Ocañas; Kyla B Tooley; Michael B Stout; Augusto Schneider; Willard M Freeman
Journal:  Mech Ageing Dev       Date:  2020-12-28       Impact factor: 5.432

9.  Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.

Authors:  E'Lissa M Flores; Collynn F Woeller; Megan L Falsetta; Martha Susiarjo; Richard P Phipps
Journal:  FASEB J       Date:  2018-10-30       Impact factor: 5.834

10.  Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS).

Authors:  Chung-Chia Liao; Shu-Chun Chen; Hui-Pei Huang; Chau-Jong Wang
Journal:  J Food Drug Anal       Date:  2017-07-08       Impact factor: 6.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.